| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
neutrophil cytosolic factor 1 | 0.521 | 0.808 | 2.8E-05 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.460 | None | 1.000 | 2 | 0 | 2009 | 2016 | ||||||||
|
TNF receptor associated factor 1 | 0.554 | 0.731 | 3.6E-03 |
|
disease | 0.500 | None | 0.850 | 2 | 0 | 2007 | 2019 | ||||||||
|
TNF receptor associated factor 6 | 0.472 | 0.808 | 1.00 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.480 | None | 1.000 | 2 | 0 | 1991 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.952 | 2 | 0 | 1994 | 2019 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.490 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.400 | None | 0.950 | 2 | 0 | 1995 | 2020 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2012 | 2020 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 0.938 | 2 | 0 | 1988 | 2020 | ||||||||
|
sprouty related EVH1 domain containing 2 | 0.711 | 0.577 | 2.9E-07 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2010 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.400 | None | 0.931 | 2 | 0 | 1998 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.852 | 2 | 0 | 2002 | 2020 | ||||||||
|
deoxyribonuclease 1 like 3 | 0.575 | 0.769 | 3.0E-05 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
T cell activation RhoGTPase activating protein | 0.700 | 0.462 | 0.85 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 0.350 | None | 0.857 | 2 | 0 | 1993 | 2018 | ||||||||
|
bone morphogenetic protein 6 | 0.531 | 0.808 | 0.76 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2010 | ||||||||
|
ceruloplasmin | 0.466 | 0.846 | 4.2E-10 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.400 | None | 0.938 | 1 | 0 | 1996 | 2019 | ||||||||
|
spermine synthase | 0.491 | 0.846 | 0.97 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
pregnancy specific beta-1-glycoprotein 5 | 0.631 | 0.615 | 8.8E-22 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
TLE family member 3, transcriptional corepressor | 0.674 | 0.462 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 |